Medicines Co
MDCO
MDCO was delisted on the 3rd of January, 2020.
201 hedge funds and large institutions have $3.16B invested in Medicines Co in 2016 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 83 increasing their positions, 73 reducing their positions, and 8 closing their positions.
188% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 8
170% more call options, than puts
Call options by funds: $106M | Put options by funds: $39.3M
14% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 73
13% more capital invested
Capital invested by funds: $2.79B → $3.16B (+$370M)
6% more funds holding
Funds holding: 190 → 201 (+11)
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$31.6M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
+$26.4M |
| 3 |
O
OppenheimerFunds
New York
|
+$22.9M |
| 4 |
First Eagle Investment Management
New York
|
+$17.5M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$16.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$43.4M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$32.8M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13.8M |
| 4 |
JP Morgan Chase
New York
|
-$12.5M |
| 5 |
Retirement Systems of Alabama
Montgomery,
Alabama
|
-$11.9M |
MDCO Hedge Fund Activity: Q3 2016 in Review
201 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q3 2016, worth a combined $3.16B — up 13% from $2.79B a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new MDCO positions and 8 closed out — a net gain of 15 holders — while 83 added to existing stakes and 73 trimmed.
The largest buyer was Wells Fargo, adding an estimated $31.6M. The largest seller was Millennium Management, cutting an estimated $43.4M.
- 201 institutional investors held Medicines Co (MDCO) as of Q3 2016, up from 190 in Q2 2016.
- Funds reported $3.16B of Medicines Co stock for Q3 2016, up 13% quarter-over-quarter.
- 23 funds opened new Medicines Co positions in Q3 2016 and 8 closed out, a net change of +15 holders.
- The largest Medicines Co buyer in Q3 2016 was Wells Fargo, an estimated $31.6M added.
- The largest Medicines Co seller in Q3 2016 was Millennium Management, an estimated $43.4M sold.
Based on aggregated 13F filings for Q3 2016.